Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death
Authors:
- Vincenzo La MuraVMVincenzo La Mura
- Enric ReverterEREnric Reverter
- Susana SeijoSSSusana Seijo
- Annalisa BerzigottiABAnnalisa Berzigotti
- Eyal AskenazhiEAEyal Askenazhi
- Juan Carlos García–PagánJGJuan Carlos García–Pagán
- Juan G. AbraldesJAJuan G. Abraldes
- Jaime BoschJBJaime Bosch
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 10 (6) , 670-676
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- High doses of β-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleedingLiver International, 2010
- Management of Varices and Variceal Hemorrhage in CirrhosisNew England Journal of Medicine, 2010
- A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleedingJournal of Gastroenterology and Hepatology, 2009
- How to Prevent Varices From Bleeding: Shades of Grey—The Case for Nonselective β BlockersGastroenterology, 2007
- Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology, 2007
- A note on competing risks in survival data analysisBritish Journal of Cancer, 2004
- Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisHepatology, 2002
- “A la carte” treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleedingHepatology, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988